Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2021

Every FDA drug recall initiated in 2021, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,152 recalls, newest first.

Class II · Moderate risk

Briviact (brivaracetam)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 50474-570-66 D-0591-2021
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0131-2480-35 D-0590-2021
Class II · Moderate risk

VIMPAT (lacosamide)

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. D-0589-2021
Class II · Moderate risk

Sulindac Tablets

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 42806-011-01 D-0582-2021
Class II · Moderate risk

Balziva 28 Day

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 0555-9034-58 D-0579-2021
Class II · Moderate risk

Proair HFA

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 59310-579-22 D-0573-2021
Class II · Moderate risk

Trokendi XR

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Terminated Temperature excursion Cardinal Health Inc. NDC 17772-103-30 D-0570-2021

Recalls by year